Zdrowie i gospodarka · 24/06/2021
FDA Releases Final Guidance for Master Protocols Evaluating COVID-19 Drugs and Biological Products
The US Food and Drug Administration (FDA) has announced the availability of a final guidance document to help pharmaceutical companies develop master protocols for clinical trials evaluating COVID-19 treatments and prevention methods, with the aim of generating substantial evidence of effectiveness and safety.